Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
NBRV was delisted on the 31st of July, 2023.
33 hedge funds and large institutions have $5.17M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.
197% more call options, than puts
Call options by funds: $1.41M | Put options by funds: $475K
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
0% more funds holding
Funds holding: 33 → 33 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
41% less capital invested
Capital invested by funds: $8.73M → $5.17M (-$3.56M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
+$389K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$250K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$210K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$150K |
| 5 |
Jane Street
New York
|
+$117K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$958K |
| 2 |
Renaissance Technologies
New York
|
-$568K |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$307K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$239K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$213K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $1K | -$35.2K | -566 | -98% |
|
|
EC
27
Estate Counselors
Thiensville,
Wisconsin
| $1K | – | – | – |
|
28
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
GIM
30
Granahan Investment Management
Waltham,
Massachusetts
| – | -$307K | -5,081 | Closed |
|
|
GCP
31
GSA Capital Partners
London,
United Kingdom
| – | -$122K | -2,022 | Closed |
|
|
CCFM
32
Clear Creek Financial Management
Silverdale,
Washington
| – | -$48K | -802 | Closed |
|
33
Simplex Trading
Chicago,
Illinois
| – | -$11.6K | -186 | Closed |
|
|
SPIA
34
Steward Partners Investment Advisory
New York
| – | -$2K | -38 | Closed |
|
|
CFD
35
Creative Financial Designs
Kokomo,
Indiana
| – | -$497 | -8 | -73% |
|
|
WAP
36
Wealthcare Advisory Partners
West Chester,
Pennsylvania
| – | +$62 | +1 | New |
|
NBRV Hedge Fund Activity: Q1 2021 in Review
33 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) for Q1 2021, worth a combined $5.17M — down 41% from $8.73M a quarter earlier.
Fund positioning in NBRV was balanced in Q1 2021: 6 funds opened new positions, 6 closed out, 8 added to existing stakes and 7 trimmed.
The largest buyer was Squarepoint, opening a new position worth an estimated $389K. The largest seller was Morgan Stanley, cutting an estimated $958K.
- 33 institutional investors held Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $5.17M of Nabriva Therapeutics plc Ordinary Shares Ireland stock for Q1 2021, down 41% quarter-over-quarter.
- 6 funds opened new Nabriva Therapeutics plc Ordinary Shares Ireland positions in Q1 2021 and 6 closed out, a net change of 0 holders.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland buyer in Q1 2021 was Squarepoint, an estimated $389K added.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland seller in Q1 2021 was Morgan Stanley, an estimated $958K sold.
Based on aggregated 13F filings for Q1 2021.